title: Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.
abstract: Dual-tracer molecular imaging is a powerful approach to quantify receptor expression in a wide range of tissues by using an untargeted tracer to account for any nonspecific uptake of a molecular-targeted tracer. This approach has previously required the pharmacokinetics of the receptor-targeted and untargeted tracers to be identical, requiring careful selection of an ideal untargeted tracer for any given targeted tracer. In this study, methodology capable of correcting for tracer differences in arterial input functions, as well as binding-independent delivery and retention, is derived and evaluated in a mouse U251 glioma xenograft model using an Affibody tracer targeted to epidermal growth factor receptor (EGFR), a cell membrane receptor overexpressed in many cancers. Simulations demonstrated that blood, and to a lesser extent vascular-permeability, pharmacokinetic differences between targeted and untargeted tracers could be quantified by deconvolving the uptakes of the two tracers in a region of interest devoid of targeted tracer binding, and therefore corrected for, by convolving the uptake of the untargeted tracer in all regions of interest by the product of the deconvolution. Using fluorescently labeled, EGFR-targeted and untargeted Affibodies (known to have different blood clearance rates), the average tumor concentration of EGFR in four mice was estimated using dual-tracer kinetic modeling to be 3.9 ± 2.4 nM compared to an expected concentration of 2.0 ± 0.4 nM. However, with deconvolution correction a more equivalent EGFR concentration of 2.0 ± 0.4 nM was measured.
authors.affiliation: Biomedical Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Tichauer
authors.forename: M
authors.initials: M
authors.lastname: Diop
authors.forename: J T
authors.initials: JT
authors.lastname: Elliott
authors.forename: K S
authors.initials: KS
authors.lastname: Samkoe
authors.forename: T
authors.initials: T
authors.lastname: Hasan
authors.forename: K
authors.initials: K
authors.lastname: St Lawrence
authors.forename: B W
authors.initials: BW
authors.lastname: Pogue
mesh_terms: D000818:Animals; D002339:Carotid Arteries / Q000378:metabolism; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D006801:Humans; D007700:Kinetics; D051379:Mice; D057054:Molecular Imaging / Q000379:methods*; D011849:Radioactive Tracers; D014018:Tissue Distribution
chemical_list: D011849:Radioactive Tracers; C512478:EGFR protein, human; D066246:ErbB Receptors
references.citation: Phys Med Biol. 2012 Oct 21;57(20):6647-59
references.pmid: 23022732
references.citation: Radiology. 2005 Apr;235(1):65-72
references.pmid: 15731376
references.citation: Cancer Res. 1995 Sep 1;55(17):3752-6
references.pmid: 7641188
references.citation: Biophys J. 2009 Mar 18;96(6):2405-14
references.pmid: 19289065
references.citation: J Biomed Opt. 2010 May-Jun;15(3):030513
references.pmid: 20614996
references.citation: Mol Imaging Biol. 2014 Jun;16(3):372-82
references.pmid: 24217944
references.citation: J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
references.pmid: 8784228
references.citation: J Cereb Blood Flow Metab. 1996 Jan;16(1):42-52
references.pmid: 8530554
references.citation: Small. 2013 Sep 23;9(18):3118-27
references.pmid: 23463664
references.citation: Nat Biotechnol. 2013 Feb;31(2):148-53
references.pmid: 23292608
references.citation: Neuroimage. 1997 Nov;6(4):279-87
references.pmid: 9417971
references.citation: Mol Imaging Biol. 2012 Oct;14(5):584-92
references.pmid: 22203241
references.citation: Neuroimage. 1996 Dec;4(3 Pt 1):153-8
references.pmid: 9345505
references.citation: Nat Biotechnol. 2004 Aug;22(8):969-76
references.pmid: 15258594
references.citation: Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15
references.pmid: 11597399
references.citation: Semin Nucl Med. 2010 May;40(3):167-81
references.pmid: 20350626
references.citation: Eur J Clin Pharmacol. 1981;20(4):299-305
references.pmid: 7308282
references.citation: Pharmacol Rev. 1951 Mar;3(1):1-41
references.pmid: 14833874
references.citation: Mol Imaging Biol. 2014 Aug;16(4):488-94
references.pmid: 24420443
references.citation: Transl Oncol. 2012 Dec;5(6):408-14
references.pmid: 23323155
references.citation: Opt Lett. 2012 Jun 15;37(12):2358-60
references.pmid: 22739907
references.citation: Ann Neurol. 1984 Mar;15(3):217-27
references.pmid: 6609679
references.citation: J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
references.pmid: 17519979
references.citation: Protein Eng Des Sel. 2007 Apr;20(4):189-99
references.pmid: 17452435